A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: A model to study Batten disease

Cellular and Molecular Neurobiology

Volumn 19, Issue 5, 1999, Pages 671-680

  Guo, Wei Xing ^a,b   Mao, Cungui ^b   Obeid, Lina M ^b   Boustany, Rose Mary ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Batten disease; Degenerative disease; PCR based gene disruption; Saccharomyces cerevisiae

Indexed keywords

ETOPOSIDE; MITOCHONDRIAL ENZYME; OLIGOMYCIN; PROTEIN KINASE C INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; STAUROSPORINE; VINCRISTINE;

ARTICLE; CELL PROLIFERATION; GENE DISRUPTION; GENE SEQUENCE; HUMAN; HUMAN CELL; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PATHOPHYSIOLOGY; PH MEASUREMENT; PHENOTYPE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE;

ALKALOSIS; ANTINEOPLASTIC AGENTS; CYCLINS; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; OLIGOMYCINS; PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0033034064     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006992704108     Document Type: Article

References (27)

1. 0-ATP synthase in cultured lymphoblasts from patients with Batten disease. J. Inher Metab. Dis. 20:457-460.
2. Bertand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. (1994). Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211:314-321.
3. Boustany, R.-M. (1992). Neurology of the neuronal ceroid lipofuscinoses. Am. J. Med. Genet. 42:533-535.
4. Boustany, R.-M., and Filipek, P. (1993). Seizures, depression and dementia in teenagers with Batten disease. J. Inher. Metab. Dis. 16:252-255.
5. Boustany, R.-M., and Kolodny, E. H. (1989). Neurological progress: the neuronal ceroid lipofuscinoses, a review. Rev. Neurol. (parid) 145:105-110.
6. Boustany, R.-M., Alroy, J., and Kolodny, E. H. (1988). Clinical classification of neuronal ceroid lipofuscinosis subtypes. Am. J. Med. Genet. 5:47-58.
7. Gietz, R. D., and Schiestl, R. (1991). Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier. Yeast 7:253-263.
8. Harmon, B. V., Takano, Y. S., Winterford, M., and Potten, C. S. (1992). Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line. Cell Prolif. 25:523-536.
9. Hartwell, L. H. (1967). Macromolecule synthesis in temperature-sensitive mutants of yeast. J. Bacteriol. 93:1662-1670.
10. Heitman, J., Movva, N. R., and Hall, M. N. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905-909.
11. Jenkins, G. M. (1998). Ph.D. thesis, Duke University Medical Center, Durham, NC, 48-64.
12. Jenkins, G. M., Richards, A., Wahl, T., Mao, C., Obeid, L., and Hannun, Y. (1997). Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae. J. Biol. Chem. 272:32566-32572.
13. Johnson, D. W., Speier, S., Qian, W. H., Lane, S., Cook, A., Suzuki, K., Daniel, P., and Boustany, R.-M. (1995). Role of subunit-9 of mitochondrial ATP synthase in Batten disease. Am. J. Med. Genet. 57:350-360.
14. Joshi, S., Cao, G. J., Nath, C., and Shah, J. (1996). Oligomycin sensitivity conferring protein of mitochondrial ATP synthase: deletions in the N-terminal end ause defects in interactions with F1, while deletions in the C-terminal end cause defects in interactions with F0. Biochemistry 35:12094-12103.
15. Kassir, Y., and Simchen, G. (1991). Monitoring meiosis and sporulation in Saccharomyces cerevisiae. Methods Enzymol. 194:94-110.
16. Katz, M. L., Gao, C.-L., Prabhakaram, M., Shibuya, H., Liu, P.-C., and Johnson, G. S. (1997). Immunochemical localization of the Batten disease (CLN3) protein in retina. Invest. Ophthalmol. Vis. Sci. 38:2375-2386.
17. Lee, R. L., Johnson, K. R., and Lerner, T. J. (1996). Isolation and chromosomal mapping of a mouse homolog of the Batten diseases gene CLN3. Genomics 35:617-619.
18. Mayashi, M., Ohkuni, K., and Yamashita, I. (1998). An extracellular meiosis-promoting factor in Saccharomyces cerevisiae. Yeast 14:617-622.
19. Mitchison, H. M., Taschner, P. E. M., Kremmidiotis, G., Callen, D. F., Doggett, N. A., Lerner, T. J., Janes, R. B., Wallace, B. A., Munroe, P. B., O'Rawe, A. M., Gardiner, R. M., and Mole, S. E. (1997). Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Neuropediatrics 28:12-14.
20. Mukhopadhyay, A., Uh, M., and Mueller, D. M. (1994). Level of ATP synthase activity required for yeast Saccharomyces cerevisiae to grow on glycerol media. FEBS Lett. 343:160-164.
21. Pearce, D. A., and Sherman, F. (1997). BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase. Yeast 13:691-697.
22. Pearce, D. A., and Sherman, F. (1998). A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. USA 95:6915-6918.
23. Puranam, K., Qian, W. H., Nikbakht, K., Venable, M., Obeid, L., Hannun, Y., and Boustany, R.-M. (1998). Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics 28:1-5.
24. Puranam, K. L., Guo, W. X., Qian, W. H., Nikbakht, K., and Boustany, R.-M. (1999). CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Mol. Genet. Metab. (in press).
25. The International Batten Disease Consortium (1995). Isolation of novel gene underlying Batten disease. Cell 82:949-957.
26. Wach, A., Brachat, A., Pohlmann, R., and Philippsen, P. (1994). New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10:1793-1808.
27. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F., and Sikorska, M. (1991). Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51:1078-1085.